title: [Direct acting oral anticoagulants in venous thromboembolism].
authors.affiliation: 1 Medizinische Klinik, Spital Uster.
authors.forename: Carla
authors.initials: C
authors.lastname: Walti
authors.forename: Esther
authors.initials: E
authors.lastname: Bächli
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D000075202:Contraindications; D000069604:Dabigatran; D004347:Drug Interactions; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D009025:Morpholines / Q000008:administration & dosage* / Q000009:adverse effects; D011655:Pulmonary Embolism / Q000097:blood / Q000188:drug therapy; D011720:Pyrazoles / Q000008:administration & dosage* / Q000009:adverse effects; D011728:Pyridones / Q000008:administration & dosage* / Q000009:adverse effects; D012008:Recurrence; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects; D054556:Venous Thromboembolism / Q000097:blood / Q000188:drug therapy*; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran